Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Diarrhea × Fulvestrant × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 132 Neoplasm Metastasis 16 Ovarian Neoplasms 7 Prostatic Neoplasms 6 Advanced Breast Cancer 5 Neoplasms 4 Breast Cancer Metastatic 4 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Exanthema 2 Estrogen Receptor-positive Breast Cancer 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Lobular 2 Breast Neoplasms, Male 2 The Neoadjuvant Therapy 1 Solid Tumor 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Sarcoma 1 Salivary Gland Neoplasms 1 Patient Acceptance of Health Care 1 Neoplastic Cells, Circulating 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Neoplasms of Female Genital Organs 1 Locoregional Recurrence 1 Hyperglycemia 1

Interventions

Loperamide 4 Irinotecan 4 Probiotics 2 Octreotide 2 Leucovorin 2 Fluorouracil 2 Calcium Aluminosilicate 2 telotristat ethyl 1 shosaiko-to 1 maltodextrin 1 ceterizine hydrochloride 1 capivasertib 1 cabazitaxel 1 bile acid binding proteins 1 XRP6258 1 Theophylline 1 Temozolomide 1 Surveys and Questionnaires 1 Sulfasalazine 1 Sugars 1 Raloxifene Hydrochloride 1 Radiation 1 Prednisone 1 Oxaliplatin 1 Long-Term Synaptic Depression 1 Injections 1 Granulocyte Colony-Stimulating Factor 1 Fulvestrant 1 Filgrastim 1 Fecal Microbiota Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡